Sponsorship Statement: This continuing education activity is jointly sponsored and co-provided by 
and 
.
Support Statement: This activity is supported by an educational grant from 
Target Audience: The intended audience for this activity is oncologists, hematologists, oncology nurses, and other health care professionals involved in the treatment of patients with cancer.
Learning Objectives:
At the conclusion of this activity, participants should be able to:
- Explain current immunotherapy strategies being evaluated in non-small cell lung cancer (NSCLC).
- Evaluate key efficacy and safety data from clinical trials of protein-based, peptide-based, and cellular-based vaccines.
- Identify effective vaccine strategies for early-stage and advanced-stage NSCLC based on patient and disease characteristics.
Course Chair:
Thomas J. Lynch Jr, MD
Jonathan and Richard Sackler Professor of Medicine
Director, Yale Cancer Center
Physician-in-Chief, Smilow Cancer Hospital
New Haven, CT
Faculty:
Paul A. Bunn Jr, MD
James Dudley Professor of Medicine
University of Colorado
Aurora, CO
Roy S. Herbst, MD, PhD
Professor of Medicine
Chief of Medical Oncology
Yale Cancer Center
Section of Medical Oncology
New Haven, CT
John V. Heymach, MD, PhD
Associate Professor
Department of Thoracic/Head and Neck Medical Oncology
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX
Nurse Planners and Reviewers
Rebecca Sipples, APRN
Oncology Nurse Practitioner
Thoracic Oncology Program
Smilow Cancer Hospital
New Haven, CT
Jeanne Griffin Vaughn, NP
Inpatient NP Unit
Massachusetts General Hospital
Boston, MA
External Reviewer:
Charles Butts, MD
Medical Writer:
Anne Jacobson, MPH, CCMEP
Accreditation:
This educational activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of HemOnc Today® and Vindico Medical Education. Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This activity is co-provided by HemOnc Today® and Vindico Medical Education. Vindico Medical Education is an approved provider of continuing nursing education by the New Jersey State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. P#188-6/2009-2012.
Credit Designation
Vindico Medical Education designates this enduring material activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education will provide 1.25 contact hours for nurses.
This enduring material is approved for 1 year from the date of original release, October 25, 2011 to October 25, 2012.
How To Participate in this Activity and Obtain CME/CE Credit:
To participate in this CME/CE activity, you must read the objectives, answer the pretest questions, read the article, complete the posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)TM or Learner Paced Contact Hours certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education's and the American Nurses Credentialing Center's Standards for Commercial Support, all CME/CE providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME/CE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME/CE activity content over which the individual has control. Relationship information appears on this page.
This activity is supported by an educational grant from EMD Serono. Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply American Nurses Credentialing Center's Commission on Accreditation endorsement of any commercial products.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s):
Paul A. Bunn Jr, MD
Consulting Fees: Bristol-Myers Squibb; Merck & Co, Inc/EMD Serono; GlaxoSmithKline
Roy S. Herbst, MD, PhD
Advisory Committee: Amgen
Grant Support/Research Funding: Amgen; AstraZeneca; Bristol-Myers Squibb; Genentech; Geron; Imclone; Novartis; Oncothyreon; OSI; Pfizer; Sanofi-aventis
Paid Consultant/Honoraria: Allos Therapeutics; Argennix, Inc; Boehringer Ingelheim; Genentech; OSI
Scientific Advisory Boards: Biotheria; Diatech; Genetics Squared; Medtrust; N of One; SynDev Rx; Targeted Molecular Diagnostics
John V. Heymach, MD, PhD
Consulting Fees: AstraZeneca; Auschon; Boehringer Ingelheim; GlaxoSmithKline; Pfizer
Contracted Research: AstraZeneca; GlaxoSmithKline; Pfizer
Thomas J. Lynch Jr, MD
Receipt of Intellectual Copyrights/Patent Holder: Partners Healthcare
Consulting Fees: Boehringer Ingelheim; Merck and Co, Inc; Supergen
Ownership Interest: Infinity
Rebecca Sipples, APRN
No relevant financial relationship to disclose
Jeanne Griffin Vaughn, NP
No relevant financial relationship to disclose
External Reviewer reports the following relationship(s):
Charles Butts, MD
Consulting Fees: EMD Serono
Medical Writer reports the following relationship(s):
Anne Jacobson, MPH, CCMEP
No relevant financial relationship to disclose
HemOnc Today® and Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2011 SLACK Incorporated®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of HemOnc Today® and Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of HemOnc Today® and Vindico Medical Education. Neither HemOnc Today®, Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.